polyethylene glycol 3350 Oral Powder Product
RxNorm concept 1870357, clinical dose form group (scdg).
- RxCUI
- 1870357
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1870357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- polyethylene glycol 3350 (IN, has ingredient)
- ClearLax Oral Powder Product (SBDG, has tradename)
- Gavilax Oral Powder Product (SBDG, has tradename)
- GentleLax Oral Powder Product (SBDG, has tradename)
- HealthyLax Oral Powder Product (SBDG, has tradename)
- Miralax Oral Powder Product (SBDG, has tradename)
- PureLax Oral Powder Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1870357 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1870357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1870357. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.